Welcome to BusinessBankruptcies.com!

Sign up for a free account to get access to data on case creditors, search for cases, and more.

Par Pharmaceutical, Inc.

COURT
New York Southern Bankruptcy Court
CASE NUMBER
7:2022bk22546
TYPE / CHAPTER
Voluntary / 11

Case Information

This case has a LEAD CASE: Endo International plc

When following such a bankruptcy, it is important to follow the lead case. When we detect a group of jointly administered cases, we mark the associated and lead cases. The case information tab of the case page will show whether a case is associated with a lead case, or is a lead case and has associated cases.

Filed

8-16-22

Updated

11-17-24

Last Checked

8-17-22

Assets

Subscribe

Liabilities

Subscribe

Get notified when your customers file for bankruptcy

Docket

Last Updated
Aug 17, 2022
Last Entry Filed
Aug 17, 2022

Docket Entries by Quarter

Aug 16, 2022 1 Petition Chapter 11 Voluntary Petition for Non-Individual. Order for Relief Entered. Case Designated As Mega as per LBR 1073-1. Chapter 11 Plan due by 12/14/2022, Disclosure Statement due by 12/14/2022, Initial Case Conference due by 9/15/2022, Filed by Paul D. Leake of Skadden, Arps, Slate, Meagher & Flom LLP on behalf of Par Pharmaceutical, Inc.. (Leake, Paul) (Entered: 08/16/2022)
Aug 16, 2022 Receipt of Voluntary Petition (Chapter 11)( 22-22546) [misc,824] (1738.00) Filing Fee. Receipt number A15881001. Fee amount 1738.00. (Re: Doc # 1) (U.S. Treasury) (Entered: 08/16/2022)
Aug 17, 2022 2 Motion for Joint Administration /Motion of the Debtors for Entry of an Order (I) Directing Joint Administration of the Chapter 11 Cases Pursuant to Bankruptcy Rule 1015(b); (II) Waiving the Requirements of Section 342(c)(1) of the Bankruptcy Code and Bankruptcy Rule 2002(n); and (III) Granting Related Relief filed by Paul D. Leake on behalf of Par Pharmaceutical, Inc.. (Leake, Paul) (Entered: 08/17/2022)

Case Information

Court
New York Southern Bankruptcy Court
Case number
7:2022bk22546
Assets
Subscribe for Access
Liabilities
Subscribe for Access
Judge
Chapter
11
Filed
Aug 16, 2022
Type
voluntary
Updated
Nov 17, 2024
Last checked
Aug 17, 2022
Lead case
Endo International plc

Associated Cases

    This case has no creditors listed.

    Parties

    Debtor

    Par Pharmaceutical, Inc.
    6 Ram Ridge Road
    Chestnut Ridge, NY 10977
    ROCKLAND-NY
    aka Par Pharmaceutical, LLC
    aka PPI Merger Sub, Inc.

    Represented By

    Paul D. Leake
    Skadden, Arps, Slate, Meagher & Flom LLP
    Four Times Square
    New York, NY 10036
    212-735-3000
    Fax : 212-735-2000
    Email: paul.leake@skadden.com

    U.S. Trustee

    United States Trustee
    Office of the United States Trustee
    U.S. Federal Office Building
    201 Varick Street, Room 1006
    New York, NY 10014
    (212) 510-0500

    Nearby Cases

    Date Filed Nameparent case = parent case Chapter Case #
    Aug 16, 2022 DAVA Pharmaceuticals, LLC parent case 11 7:2022bk22558
    Aug 16, 2022 Anchen Pharmaceuticals, Inc. parent case 11 7:2022bk22556
    Aug 16, 2022 Generics International (US), Inc. parent case 11 7:2022bk22554
    Aug 16, 2022 Anchen Incorporated parent case 11 7:2022bk22552
    Aug 16, 2022 Vintage Pharmaceuticals, LLC parent case 11 7:2022bk22586
    Aug 16, 2022 Quartz Specialty Pharmaceuticals, LLC parent case 11 7:2022bk22584
    Aug 16, 2022 Par, LLC parent case 11 7:2022bk22582
    Aug 16, 2022 Par Sterile Products, LLC parent case 11 7:2022bk22580
    Aug 16, 2022 Par Pharmaceutical Holdings, Inc. parent case 11 7:2022bk22578
    Aug 16, 2022 Par Pharmaceutical Companies, Inc. parent case 11 7:2022bk22576
    Aug 16, 2022 Moores Mill Properties L.L.C. parent case 11 7:2022bk22574
    Aug 16, 2022 Kali Laboratories, LLC parent case 11 7:2022bk22572
    Aug 16, 2022 JHP Group Holdings, LLC parent case 11 7:2022bk22569
    Aug 16, 2022 JHP Acquisition, LLC parent case 11 7:2022bk22567
    Aug 16, 2022 Innoteq, Inc. parent case 11 7:2022bk22565